Clostridium difficile Infection: New Insights into Management

submitted by: WentzMR
Dr. Sahil Khanna, Assistant Professor of Medicine and a Clinician Investigator Fellow in Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the November 2012 issue of Mayo Clinic Proceedings, where he provides a state-of-the-art update on the treatment for patients with Clostridium difficile infection. Available at: http://www.mayoclinicproceedings.org/article/ S0025-6196(12)00814-2/fulltext

Clostridium difficile Infection in Patients With Chronic Kidney Disease

submitted by: WentzMR

Dr. Mira Keddis, Instructor of Medicine and third year fellow in Nephrology at Mayo Clinic in Rochester, MN, discusses her article appearing in the November 2012 issue of Mayo Clinic Proceedings, which demonstrates that patients with Chronic Kidney disease are at a higher risk of Clostridium Difficile Infection.
Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00848-8/fulltext

Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study.

submitted by: WentzMR

Dr. Sahil Khanna, Gastroenterology Fellow at Mayo Clinic in Rochester, MN, discusses his article appearing in the July 2012 issue of Mayo Clinic Proceedings on the effects of medications, including proton pump inhibitors (PPI) and histamine type 2 (H2) blockers, on outcomes in patients with Clostridium difficile infection (CDI) in a population-based cohort. Available at: http://www.mayoclinicproceedings.org/article/S0025-6196(12)00483-1/fulltext